LVCLF
Price:
$0.00425
Market Cap:
$11.03M
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.[Read more]
Industry
Biotechnology
IPO Date
2010-06-01
Stock Exchange
PNK
Ticker
LVCLF
According to Living Cell Technologies Limited’s latest financial reports and current stock price. The company's current Current Ratio is 17.89. This represents a change of -19.96% compared to the average of 22.35 of the last 4 quarters.
The mean historical Current Ratio of Living Cell Technologies Limited over the last ten years is 11.14. The current 17.89 Current Ratio has changed 15.95% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's Current Ratio was at its highest in in the September 2023 quarter at 26.81. The Current Ratio was at its lowest in in the March 2019 quarter at 3.33.
Average
11.14
Median
9.61
Minimum
3.33
Maximum
17.89
Discovering the peaks and valleys of Living Cell Technologies Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 286.08%
Maximum Annual Current Ratio = 17.89
Minimum Annual Increase = -78.01%
Minimum Annual Current Ratio = 3.33
Year | Current Ratio | Change |
---|---|---|
2024 | 17.89 | 91.31% |
2023 | 9.35 | -47.58% |
2022 | 17.84 | 190.88% |
2021 | 6.13 | -37.90% |
2020 | 9.88 | 196.69% |
2019 | 3.33 | -78.01% |
2018 | 15.14 | 117.70% |
2017 | 6.95 | -23.39% |
2016 | 9.08 | -42.77% |
2015 | 15.86 | 286.08% |
The current Current Ratio of Living Cell Technologies Limited (LVCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
15.03
5-year avg
12.22
10-year avg
11.14
Living Cell Technologies Limited’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Living Cell Technologies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Living Cell Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Living Cell Technologies Limited's Current Ratio?
How is the Current Ratio calculated for Living Cell Technologies Limited (LVCLF)?
What is the highest Current Ratio for Living Cell Technologies Limited (LVCLF)?
What is the 3-year average Current Ratio for Living Cell Technologies Limited (LVCLF)?
What is the 5-year average Current Ratio for Living Cell Technologies Limited (LVCLF)?
How does the current Current Ratio for Living Cell Technologies Limited (LVCLF) compare to its historical average?